Carlos Williams, MD
Orthopaedic Surgery · Melbourne, FLNPI 1346552015
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $12,154 of the $18,528 with a category attached, or 65.6%. 12 manufacturers reported payments, led by Stryker at 41.9% of the total. Reporting peaked in 2022 at $5,358 and has fallen 94.5% since, to $295 in 2025.
Across 109 payments — averaging $169.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$8K
- Smith+Nephew$5K
- Zimmer Biomet$3K
- Steelhead Surgical Inc$1K
- Johnson & Johnson$446
- Biogen$304
- plus $382 from 6 others
What the payments were for
- Travel & lodging$12,15466%
- Food & beverage$5,15428%
- Education$1,2207%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 45 | $7,761 |
| Smith+Nephew | 21 | $5,317 |
| Zimmer Biomet | 8 | $3,118 |
| Steelhead Surgical Inc | 1 | $1,200 |
| Johnson & Johnson | 2 | $446 |
| Biogen | 20 | $304 |
| Medtronic | 1 | $178 |
| Biohaven Pharmaceuticals, Inc. | 4 | $51 |
| Eisai Inc. | 3 | $50 |
| Heron Therapeutics, Inc. | 1 | $50 |
| Lilly USA, LLC | 2 | $30 |
| Medical Device Business Services, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$6,594
- Journey II$1,951
- Legion Revision$1,811
- REDAPT$1,746
- Avenir$1,479
- REAL INTELLIGENCE$1,388
- R3 ACETABULAR$1,335
- Tandem$1,243
- Journey II BCS$1,114
- Navio Surgical System$913
- Anthology$853
- Persona$741
- ACTIS$446
- VISIONAIRE$303
- Legion$303
- REDAPT Revision Hip System$267
- AQUAMANTYS$178
- INSIGNIA$169
- NexGen$146
- OSS Orthopedic Salvage System$146
How this compares
$18,528 in reported general payments places this provider in the 70th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 39 | $316 |
| Oxycodone Hcl | 18 | $145 |
| Meloxicam | 44 | $112 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Melbourne
- Richard HynesMelbourne$34.8M
- Kenneth SandsMelbourne$407K
- Andrew CooperClearwater$102M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.